Rumex japonicus Houtt. alleviates dextran sulfate sodium-induced colitis by protecting tight junctions in mice

Drewes, 2006, Pain and mechanical properties of the rectum in patients with active ulcerative colitis, Inflamm Bowel Dis, 12, 294, 10.1097/01.MIB.0000209365.09189.04 Shih, 2008, Immunopathogenesis of inflammatory bowel disease, World J Gastroenterol, 14, 390, 10.3748/wjg.14.390 Soderholm, 2004, Increased epithelial uptake of protein antigens in the ileum of Crohn’s disease mediated by tumour necrosis factor alpha, Gut, 53, 1817, 10.1136/gut.2004.041426 Round, 2009, The gut microbiota shapes intestinal immune responses during health and disease, Nat Rev Immunol, 9, 313, 10.1038/nri2515 Guinane, 2013, Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ, Therap Adv Gastroenterol, 6, 295, 10.1177/1756283X13482996 Molodecky, 2012, Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, Gastroenterology, 142, 10.1053/j.gastro.2011.10.001 Ko, 2014, Inflammatory bowel disease: Etiology, pathogenesis and current therapy, Curr Pharm Des, 20, 1082, 10.2174/13816128113199990416 Zenlea, 2014, Immunosuppressive therapies for inflammatory bowel disease, World J Gastroenterol, 20, 3146, 10.3748/wjg.v20.i12.3146 Lichtenstein, 2010, Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis - a 6-month placebo-controlled trial, Aliment Pharmacol Ther, 32, 990, 10.1111/j.1365-2036.2010.04438.x Wang, 2016, Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis, Cochrane Database Syst Rev Ekor, 2014, The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety, Front Pharmacol, 4, 177, 10.3389/fphar.2013.00177 M’Koma, 2013, Inflammatory bowel disease: an expanding global health problem, Clin Med Insights Gastroenterol, 6, 33 Masaru, 1986, Flavonoids in the leaves of twenty-eight polygonaceous plants, Bot Mag Tokyo, 99, 63, 10.1007/BF02488623 Nam, 2004, Isolation of anthraquinone derivatives from the root of Rumex japonicus H, Appl Biol Chem, 47, 274 Jiang, 2007, Oxanthrone C-glycosides and epoxynaphthoquinol from the roots of Rumex japonicus, Phytochemistry, 68, 2444, 10.1016/j.phytochem.2007.05.032 Zhou, 2005, [Study on the chemical constituents from Rumex japonicus Houtt], Zhong Yao Cai, 28, 104 Xie, 2014, Anti-proliferative of physcion 8-O-beta-glucopyranoside isolated from Rumex japonicus Houtt. On A549 cell lines via inducing apoptosis and cell cycle arrest, BMC Complement Altern Med, 14, 377, 10.1186/1472-6882-14-377 Vasas, 2015, The Genus Rumex: Review of traditional uses, phytochemistry and pharmacology, J Ethnopharmacol, 175, 198, 10.1016/j.jep.2015.09.001 Cho, 2011, Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis, J Ethnopharmacol, 136, 428, 10.1016/j.jep.2010.04.047 Shin, 2014, Anti-inflammatory effect of a standardized triterpenoid-rich fraction isolated from Rubus coreanus on dextran sodium sulfate-induced acute colitis in mice and LPS-induced macrophages, J Ethnopharmacol, 158, 291, 10.1016/j.jep.2014.10.044 Chassaing, 2014, Dextran sulfate sodium (DSS)-induced colitis in mice, Curr Protoc Immunol, 104, 10.1002/0471142735.im1525s104 Perse, 2012, Dextran sodium sulphate colitis mouse model: Traps and tricks, J Biomed Biotechnol, 2012, 10.1155/2012/718617 Rose, 2012, Multifunctional role of dextran sulfate sodium for in vivo modeling of intestinal diseases, BMC Immunol, 13, 41, 10.1186/1471-2172-13-41 Mizoguchi, 2012, Animal models of inflammatory bowel disease, Prog Mol Biol Transl Sci, 105, 263, 10.1016/B978-0-12-394596-9.00009-3 Barton, 2008, A calculated response: Control of inflammation by the innate immune system, J Clin Invest, 118, 413, 10.1172/JCI34431 Landy, 2016, Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer, World J Gastroenterol, 22, 3117, 10.3748/wjg.v22.i11.3117 Bhat, 2018, Tight junction proteins and signaling pathways in Cancer and inflammation: A functional crosstalk, Front Physiol, 9, 1942, 10.3389/fphys.2018.01942 Amasheh, 2002, Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells, J Cell Sci, 115, 4969, 10.1242/jcs.00165 Rosenthal, 2010, Claudin-2, a component of the tight junction, forms a paracellular water channel, J Cell Sci, 123, 1913, 10.1242/jcs.060665 Luettig, 2015, Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation, Tissue Barriers, 3, 10.4161/21688370.2014.977176 Schmitz, 1999, Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6, J Cell Sci, 112, 137, 10.1242/jcs.112.1.137 Poritz, 2007, Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis, J Surg Res, 140, 12, 10.1016/j.jss.2006.07.050 Poritz, 2011, Increase in the tight junction protein claudin-1 in intestinal inflammation, Dig Dis Sci, 56, 2802, 10.1007/s10620-011-1688-9 Weber, 2008, Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation, Lab Invest, 88, 1110, 10.1038/labinvest.2008.78 John, 2011, Epithelial barriers in intestinal inflammation, Antioxid Redox Signal, 15, 1255, 10.1089/ars.2011.3892 Fries, 2008, Dynamics of enterocyte tight junctions: Effect of experimental colitis and two different anti-TNF strategies, Am J Physiol Gastrointest Liver Physiol, 294, G938, 10.1152/ajpgi.00469.2007 Araki, 2010, Increased apoptosis and decreased proliferation of colonic epithelium in dextran sulfate sodium-induced colitis in mice, Oncol Rep, 24, 869, 10.3892/or.2010.869 Chang, 2007, Loss of p53 enhances the induction of colitis-associated neoplasia by dextran sulfate sodium, Carcinogenesis, 28, 2375, 10.1093/carcin/bgm134 DuBois, 1994, Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells, Am J Physiol, 266, G822 Taketo, 1998, Cyclooxygenase-2 inhibitors in tumorigenesis (part I), J Natl Cancer Inst, 90, 1529, 10.1093/jnci/90.20.1529 Boolbol, 1996, Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis, Cancer Res, 56, 2556 DuBois, 1996, Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors, Gastroenterology, 110, 1259, 10.1053/gast.1996.v110.pm8613017 Reddy, 1996, Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis, Cancer Res, 56, 4566 el-Deiry, 1998, Regulation of p53 downstream genes, Semin Cancer Biol, 8, 345, 10.1006/scbi.1998.0097 Deng, 1995, Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control, Cell, 82, 675, 10.1016/0092-8674(95)90039-X Popp, 2016, Expression profile of p53 and p21 in large bowel mucosa as biomarkers of inflammatory-related carcinogenesis in ulcerative colitis, Dis Markers, 2016, 10.1155/2016/3625279